tDCS in Post-Acute COVID-19 Patients With SARDs

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 17, 2021

Primary Completion Date

May 6, 2024

Study Completion Date

December 4, 2024

Conditions
Rheumatic DiseasesAutoimmune Diseases
Interventions
DEVICE

Transcranial direct current stimulation

tDCS: the energy of the anode (transcranial current stimulation) will have as its source a battery-powered DC generator and will be exerted by two electrodes measuring 5x7cm and attached to the head. The electrodes will be located of the primary motor cortex. The electrode with positive charge (anode) will be positioned at contralateral to the dominant limb and the negative charged electrode will be positioned in the supraorbital region ipsilateral to the dominant limb. The active current of direct transcranial stimulation will be applied with the intensity of electric current of 2mA and density of 0.057 mA/cm2 with duration of 20 minutes. During the session, patients will remain seated. Number of sessions: five times, once per day.

Trial Locations (1)

Unknown

RECRUITING

Samuel K Shinjo, São Paulo

All Listed Sponsors
lead

University of Sao Paulo

OTHER